Gene therapy for gastric diseases

Shintaro Fumoto1, Junya Nishi, Junzo Nakamura

  • 1Graduate School of Biomedical Sciences, Nagasaki University, Japan.

Current Gene Therapy
|June 10, 2008
PubMed

Insights

Gene therapy offers a promising approach for gastric cancer and ulcers by targeting specific genes. Developing selective delivery systems is crucial for effective and safe stomach-specific treatments.

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • Gene therapy is a viable strategy for gastric cancer and ulcers due to gene-disease correlations.
  • Non-target gene expression can lead to adverse effects, necessitating targeted delivery systems.

Purpose of the Study:

  • To review stomach- and cancer-targeted gene transfer methods.
  • To summarize current gene therapy trials for gastric cancer and gastric ulcer.

Main Methods:

  • Discussion of various vector transfer routes (e.g., direct injection, oral administration).
  • Categorization of gastric cancer gene therapy strategies (e.g., suicide gene therapy, immunotherapy).
  • Identification of potential therapeutic genes for gastric ulcer (e.g., VEGF, angiopoietin-1).

Main Results:

  • Selective gene delivery to the stomach and cancer cells is essential for efficacy and safety.
  • Combination therapies (gene + chemotherapy/virotherapy) show promise.
  • Specific genes like VEGF and cathelicidin are candidates for gastric ulcer treatment.

Conclusions:

  • Targeted gene therapy holds significant potential for treating gastric cancer and ulcers.
  • Further development of targeted delivery systems and combination strategies is warranted.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...